Anakinra (brand name Kineret) is an injectable biologic medicine that blocks interleukin-1, a natural protein that causes severe inflammation and tissue damage. It is FDA-approved to treat moderate-to-severe rheumatoid arthritis, Neonatal-Onset Multisystem Inflammatory Disease (NOMID), and Deficiency of Interleukin-1 Receptor Antagonist (DIRA)
Anakinra (brand name Kineret) is an injectable biologic medicine that blocks interleukin-1, a natural protein that causes severe inflammation and tissue damage. It is FDA-approved to treat moderate-to-severe rheumatoid arthritis, Neonatal-Onset Multisystem Inflammatory Disease (NOMID), and Deficiency of Interleukin-1 Receptor Antagonist (DIRA)